38 completed, 15 unknown, 8 recruiting, 5 active not recruiting. 23 Phase 1, 13 Phase 2, 8 Not applicable, 3 Phase 3, 1 Phase 4.
Follow RSV Infection: new trials by email Literature Review of RSV Infection trials Research Report on RSV Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The EMBRACE Study: Enflonsia Monoclonal in Babies - RSV Antibody Concentration Evaluation Clesrovimab - RSV Infection | Phase 4 | Not yet recruiting | Emory University | 24 | 2026-09-01 | 2026-09-17 |
| A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus zelicapavir, Placebo - RSV Infection, RSV | Phase 2 | Recruiting | Enanta Pharmaceuticals, Inc | 150 | 2026-07-09 | 2026-07-20 |
| Safety and Immunogenicity Study of SCB-1019T in Children low dose SCB-1019T, adjuvanted low dose SCB-1019T, high dose SCB-1019T - RSV Infection | Phase 1 | Withdrawn | Clover Biopharmaceuticals AUS Pty | 2025-10-01 | 2024-12-31 | |
| Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults SCB-1019T, SCB-1022, SCB-1033 - RSV Infection, Human Metapneumovirus Infection | Phase 1 / Phase 2 | Active not recruiting | Clover Biopharmaceuticals AUS Pty | 612 | 2025-06-18 | 2026-10-26 |
| Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France Questionnaire - RSV Infection | Recruiting | Assistance Publique - Hôpitaux de Paris | 400 | 2025-06-17 | 2025-06-24 | |
| A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose RSVpreF, Placebo - RSV Infection | Phase 3 | Recruiting | Pfizer | 550 | 2025-04-16 | 2026-10-14 |
| Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults Candidate vaccine, SCB-1019T, AREXVY, placebo - RSV Infection | Phase 1 | Recruiting | Clover Biopharmaceuticals USA, LLC | 160 | 2025-03-21 | 2025-05-14 |
| A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants EDP-323, Midazolam, Caffeine - RSV Infection, Drug Drug Interaction | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 24 | 2025-03-13 | 2025-07-01 |
| Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection Obeldesivir, Obeldesivir Placebo - RSV Infection | Phase 2 | Terminated | Gilead Sciences | 4 | 2025-03-05 | 2026-06-08 |
| A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323. EDP-323, Itraconazole, carbamazepine - RSV Infection, Drug Drug Interaction (DDI) | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 48 | 2025-01-27 | 2025-07-01 |
| Real-World Effectiveness of Perinatal RSV Immunoprophylaxis Nirsevimab - RSV Infection | Recruiting | Yale University | 3750 | 2024-10-28 | 2026-10-23 | |
| Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection Obeldesivir, Obeldesivir Placebo - RSV Infection | Phase 2 | Terminated | Gilead Sciences | 150 | 2024-10-14 | 2026-06-30 |
| CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools Daily Influenza, RSV or SARS-CoV-2 PCR testing for 14 days - SARS CoV 2 Infection, RSV Infection | Active not recruiting | The Hospital for Sick Children | 500 | 2024-10-10 | 2026-05-01 | |
| Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years RSV/hMPV vaccine dose A1, RSV/hMPV vaccine dose A2, RSV/hMPV vaccine dose A3 - RSV Infection, hMPV | Phase 1 | Completed | Sanofi Pasteur, a Sanofi Company | 385 | 2024-10-09 | 2025-11-20 |
| RSV Vaccination in Immunocompromised Patients. Arexvy powder and suspension for injection - RSV Infection | Phase 2 | Recruiting | Medical University of Vienna | 200 | 2024-09-19 | 2024-11-27 |
| A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults LYB005 low dose without adjuvant, LYB005 middle dose without adjuvant, LYB005 high dose without adjuvant - Respiratory Syncytial Virus (RSV), RSV Infection | Phase 1 | Active not recruiting | Guangzhou Patronus Biotech Co., Ltd. | 84 | 2024-07-31 | 2025-03-13 |
| A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults zelicapavir (therapeutic dose), zelicapavir (supratherapeutic dose), Placebo - RSV Infection, QTc Interval | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 72 | 2024-07-15 | 2025-07-28 |
| Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection Influenza A Infection, Influenza B Virus Infection | Enrolling by invitation | Karolinska Institutet | 800 | 2024-01-01 | 2024-05-07 | |
| Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control PCR - Asthma, Pertussis | Unknown | Hospital Clinico Universitario de Santiago | 784 | 2023-12-21 | 2024-03-01 | |
| Epidemiological and Clinical Characteristics of Hospitalized Patients Under 5 Years Old With RSV Infection in Central China, Wuhan Observation - RSV Infection | Unknown | Tongji Hospital | 10000 | 2023-12-05 | 2024-04-22 |
Showing 20 of 76. Sign in to see all of them.
Respiratory Syncytial Virus Infections (76) · COVID-19 (11) · Bronchiolitis (7) · Influenza, Human (5) · Asthma (4) · Respiratory Tract Infections (4) · Pneumonia (2) · Whooping Cough (2) · Bronchial Hyperreactivity (1) · Bronchiolitis, Viral (1) · Bronchopulmonary Dysplasia (1) · Caregiver Burden (1) · Coronavirus Infections (1) · Health Behavior (1) · Heart Failure (1)
Infections (76) · Mononegavirales Infections (76) · Pneumovirus Infections (76) · Paramyxoviridae Infections (75) · RNA Virus Infections (75) · Virus Diseases (75) · Respiratory Tract Diseases (22) · Lung Diseases (20) · Respiratory Tract Infections (18) · Coronaviridae Infections (11) · Nidovirales Infections (11) · Pneumonia (11) · Pneumonia, Viral (11) · Bronchial Diseases (10) · Coronavirus Infections (10)
EDP-938 (7) · nirsevimab (3) · Fluconazole (2) · Itraconazole (2) · Midazolam (2) · Quinidine (2) · Rosuvastatin Calcium (2) · gontivimab (2) · Adjuvants, Pharmaceutic (1) · Air (1) · Blood Specimen Collection (1) · Caffeine (1) · Carbamazepine (1) · Cohort Studies (1) · Cyclosporine (1)
Enanta Pharmaceuticals, Inc (13) · Hospices Civils de Lyon (4) · Gilead Sciences (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · UMC Utrecht (3) · Ablynx, a Sanofi company (2) · Clover Biopharmaceuticals AUS Pty (2) · LumiraDx UK Limited (2) · Pfizer (2) · Assistance Publique - Hôpitaux de Paris (1) · Association Clinique Thérapeutique Infantile du val de Marne (1) · AstraZeneca (1) · Baebies, Inc. (1) · Bavarian Nordic (1) · Beijing Children's Hospital (1)
United States (31) · United Kingdom (14) · France (6) · Spain (6) · Australia (5) · Netherlands (5) · Belgium (4) · China (4) · South Africa (4) · Japan (3) · Poland (3) · Turkey (Türkiye) (3) · Argentina (2) · Canada (2) · Colombia (2)
Ruth A. Karron, MD (3) · Benjamin Meyer, Dr. (1) · Candice Prowse (1) · Carlos R Oliveira, MD (1) · Christina Chang, M.D (1) · Christina Rostad, MD (1) · Christopher Chiu (1) · Christopher D Rook, MD (1) · Gerdien Tramper, MD, PhD (1) · Graham McLennan, MS (1)
PMID 32702120, PMID 32794574, PMID 33060153, PMID 34260480, PMID 34296674, PMID 34904176, PMID 34908153, PMID 35134954, PMID 35172056, PMID 35961055, PMID 36098319, PMID 36372082, PMID 37079393, PMID 37493269, PMID 37936699, PMID 38424744, PMID 38531725, PMID 38701823, PMID 38713818, PMID 38738683, PMID 38767780, PMID 38900603, PMID 39052716, PMID 39441691, PMID 39627701, PMID 39674537, PMID 39674538, PMID 39696004, PMID 39893316, PMID 40314706, PMID 40343736, PMID 40602662, PMID 40961423, PMID 41247054, PMID 41379208, PMID 41539320, PMID 41856594, PMID 41862086, PMID 42475081, PMID 42507294
2023 (1), R01AI179874 (1)